Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Calabrese

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Managed Care & Specialty Pharmacy|January 2, 2018
Future Considerations for the Evaluation of Hepatitis C Virus Treatments in Pan-Genotypic Therapy for Noncirrhotic Treatment-Naive PatientsMartin J Calabrese, Lauren M Hynicka, Magaly Rodriguez de Bittner, et al.
Journal of Opioid Management|May 3, 2024
State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid usersMartin J Calabrese, Fadia T Shaya, Francis Palumbo, et al.
Journal of Opioid Management|March 27, 2024
Short-term healthcare resource utilization associated with receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid usersMartin J Calabrese, Fadia T Shaya, Francis Palumbo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Managed Care & Specialty Pharmacy|January 2, 2018
Future Considerations for the Evaluation of Hepatitis C Virus Treatments in Pan-Genotypic Therapy for Noncirrhotic Treatment-Naive PatientsMartin J Calabrese, Lauren M Hynicka, Magaly Rodriguez de Bittner, et al.
Journal of Opioid Management|May 3, 2024
State-level policies and receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid usersMartin J Calabrese, Fadia T Shaya, Francis Palumbo, et al.
Journal of Opioid Management|March 27, 2024
Short-term healthcare resource utilization associated with receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid usersMartin J Calabrese, Fadia T Shaya, Francis Palumbo, et al.
Pageof 1